Application of Metabolomics to Cardiovascular Biomarker and Pathway Discovery

Journal of the American College of Cardiology

Volumn 52, Issue 2, 2008, Pages 117-123

  Lewis, Gregory D ^a,b,c   Asnani, Aarti ^a,b   Gerszten, Robert E ^a,b,c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

biomarkers; metabolomics; prognosis

Indexed keywords

AMINO ACID; BIOLOGICAL MARKER; CARBOXYLIC ACID; LIPID; NUCLEOTIDE; SUGAR;

BLOOD ANALYSIS; BLOOD LEVEL; CARDIOVASCULAR DISEASE; HUMAN; MASS SPECTROMETRY; METABOLISM; METABOLITE; METABOLOMICS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PHENOTYPE; PRIORITY JOURNAL; REVIEW;

BIOLOGICAL MARKERS; BIOMEDICAL TECHNOLOGY; CARDIOVASCULAR DISEASES; HUMANS; METABOLIC NETWORKS AND PATHWAYS; MODELS, CARDIOVASCULAR;

EID: 45849145091     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2008.03.043     Document Type: Review

References (39)

1. Pauling L., Robinson A.B., Teranishi R., and Cary P. Quantitative analysis of urine vapor and breath by gas-liquid partition chromatography. Proc Natl Acad Sci U S A 68 (1971) 2374-2376
2. Horning E.C., and Horning M.G. Metabolic profiles: gas-phase methods for analysis of metabolites. Clin Chem 17 (1971) 802-809
3. Nicholson J.K., Lindon J.C., and Holmes E. "Metabonomics": understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 29 (1999) 1181-1189
4. Raamsdonk L.M., Teusink B., Broadhurst D., et al. A functional genomics strategy that uses metabolome data to reveal the phenotype of silent mutations. Nat Biotechnol 19 (2001) 45-50
5. Allen J., Davey H.M., Broadhurst D., et al. High-throughput classification of yeast mutants for functional genomics using metabolic footprinting. Nat Biotechnol 21 (2003) 692-696
6. An J., Muoio D.M., Shiota M., et al. Hepatic expression of malonyl-CoA decarboxylase reverses muscle, liver and whole-animal insulin resistance. Nat Med 10 (2004) 268-274
7. Roe C.R., Millington D.S., and Maltby D.A. Identification of 3-methylglutarylcarnitine. A new diagnostic metabolite of 3-hydroxy-3-methylglutaryl-coenzyme A lyase deficiency. J Clin Invest 77 (1986) 1391-1394
8. Frazier D.M., Millington D.S., McCandless S.E., et al. The tandem mass spectrometry newborn screening experience in North Carolina: 1997-2005. J Inherit Metab Dis 29 (2006) 76-85
9. Wishart D.S., Tzur D., Knox C., et al. HMDB: the Human Metabolome Database. Nucleic Acids Res 35 (2007) D521-D526
10. Human Metabolome Project. The Human Metabolome Database. http://www.hmdb.ca Accessed March 2008
11. KEGG: Kyoto Encyclopedia of Genes and Genomes. http://www.genome.jp/kegg/ Accessed March 2008
12. Dunn W.B., Bailey N.J., and Johnson H.E. Measuring the metabolome: current analytical technologies. Analyst 130 (2005) 606-625
13. Dunn W.B., and Ellis D. Metabolomics: current analytical platforms and methodologies. Trends Anal Chem 4 (2005) 285-294
14. Lindon J.C., Holmes E., and Nicholson J.K. Metabonomics techniques and applications to pharmaceutical research and development. Pharm Res 23 (2006) 1075-1088
15. Backstrom T., Goiny M., Lockowandt U., Liska J., and Franco-Cereceda A. Cardiac outflow of amino acids and purines during myocardial ischemia and reperfusion. J Appl Physiol 94 (2003) 1122-1128
16. Mei D.A., Gross G.J., and Nithipatikom K. Simultaneous determination of adenosine, inosine, hypoxanthine, xanthine, and uric acid in microdialysis samples using microbore column high-performance liquid chromatography with a diode array detector. Anal Biochem 238 (1996) 34-39
17. Zemgulis V., Ronquist G., Bjerner T., et al. Energy-related metabolites during and after induced myocardial infarction with special emphasis on the reperfusion injury after extracorporeal circulation. Acta Physiol Scand 171 (2001) 129-143
18. Cheng L.L., Chang I.W., Louis D.N., and Gonzalez R.G. Correlation of high-resolution magic angle spinning proton magnetic resonance spectroscopy with histopathology of intact human brain tumor specimens. Cancer Res 58 (1998) 1825-1832
19. Zhang X., Wei D., Yap Y., Li L., Guo S., and Chen F. Mass spectrometry-based "omics" technologies in cancer diagnostics. Mass Spectrom Rev 26 (2007) 403-431
20. Human Metabolome Project. What is metabolomics?. http://www.metabolomics.ca/About/overview.htm Accessed March 2008
21. Storey J.D., and Tibshirani R. Statistical significance for genomewide studies. Proc Natl Acad Sci U S A 100 (2003) 9440-9445
22. Tavazoie S., Hughes J.D., Campbell M.J., Cho R.J., and Church G.M. Systematic determination of genetic network architecture. Nat Genet 22 (1999) 281-285
23. Mootha V.K., Lindgren C.M., Eriksson K.F., et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 34 (2003) 267-273
24. Berriz G.F., King O.D., Bryant B., Sander C., and Roth F.P. Characterizing gene sets with FuncAssociate. Bioinformatics 19 (2003) 2502-2504
25. van der Greef J., Stroobant P., and van der Heijden R. The role of analytical sciences in medical systems biology. Curr Opin Chem Biol 8 (2004) 559-565
26. Manly B. Multivariable Statistical Methods: A Primer (1994), Chapman & Hall, London
27. Bishop C. Neural Networks for Pattern Recognition (1995), Clarendon Press, Oxford
28. Baxter I.R., and Borevitz J.O. Mapping a plant's chemical vocabulary. Nat Genet 38 (2006) 737-738
29. Villas-Boas S.G., Moxley J.F., Akesson M., Stephanopoulos G., and Nielsen J. High-throughput metabolic state analysis: the missing link in integrated functional genomics of yeasts. Biochem J 388 (2005) 669-677
30. Gibala M.J., Young M.E., and Taegtmeyer H. Anaplerosis of the citric acid cycle: role in energy metabolism of heart and skeletal muscle. Acta Physiol Scand 168 (2000) 657-665
31. Bederman I.R., Reszko A.E., Kasumov T., et al. Zonation of labeling of lipogenic acetyl-CoA across the liver: implications for studies of lipogenesis by mass isotopomer analysis. J Biol Chem 279 (2004) 43207-43216
32. He W., Miao F.J., Lin D.C., et al. Citric acid cycle intermediates as ligands for orphan G-protein-coupled receptors. Nature 429 (2004) 188-193
33. Kirschenlohr H.L., Griffin J.L., Clarke S.C., et al. Proton NMR analysis of plasma is a weak predictor of coronary artery disease. Nat Med 12 (2006) 705-710
34. Sabatine M.S., Liu E., Morrow D.A., et al. Metabolomic identification of novel biomarkers of myocardial ischemia. Circulation 112 (2005) 3868-3875
35. Howarth K.R., LeBlanc P.J., Heigenhauser G.J., and Gibala M.J. Effect of endurance training on muscle TCA cycle metabolism during exercise in humans. J Appl Physiol 97 (2004) 579-584
36. Mayr M., Yusuf S., Weir G., et al. Combined metabolomic and proteomic analysis of human atrial fibrillation. J Am Coll Cardiol 51 (2008) 585-594
37. Samani N.J., Erdmann J., Hall A.S., et al. Genomewide association analysis of coronary artery disease. N Engl J Med 357 (2007) 443-453
38. McPherson R., Pertsemlidis A., Kavaslar N., et al. A common allele on chromosome 9 associated with coronary heart disease. Science 316 (2007) 1488-1491
39. Helgadottir A., Thorleifsson G., Manolescu A., et al. A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science 316 (2007) 1491-1493